What's New :
Target PT - Prelims Classes 2025. Visit Here
25th July 2024 (10 Topics)

Transfer technology for detection of tuberculosis (TB)

Context

The Indian Council of Medical Research (ICMR) has initiated efforts to introduce an affordable, rapid, and user-friendly testing technology for detecting tuberculosis (TB). This move comes in response to the staggering toll of TB in India, which claims an estimated 480,000 lives annually.

About the Technology

  • ICMR has developed a pioneering TB detection system based on CRISPR Cas technology.
  • This system, considered the world’s most economical for TB testing, utilizes DNA from saliva samples.
  • It can identify TB bacteria early and process over 1,500 samples simultaneously in about two hours, making it suitable even for primary health centers in rural areas.
  • Challenges in TB Diagnosis: India faces challenges in TB diagnosis, with a significant number of cases going unreported or inadequately treated, especially in the private sector.

About Tuberculosis (TB)

  • TB is caused by a bacterium known as Mycobacterium tuberculosis, which belongs to a family of around 200 bacteria species called Mycobacteriaceae.
  • Types of TB: TB primarily affects the lungs (pulmonary TB) in humans. However, it can also affect other organs (extra-pulmonary TB).
  • Historical Context: TB is an ancient disease, with evidence of its existence dating back to 3000 BC in Egypt.
  • Treatability: TB is treatable and curable with appropriate medication and management.
  • Transmission: TB spreads from person to person through the air. When individuals with lung TB cough, sneeze, or spit, they release TB germs into the air, which can be inhaled by others.
  • Treatment:Current biomedical strategies to reduce new infections include the
    • BCG vaccine, which protects against severe forms of childhood TB
    • Tuberculosis preventive treatment (TPT) which aims to cover other household contacts, clinical-risk groups apart from children younger than five years and household contacts with HIV
    • Effective rifamycin-based regimes

World TB Report 2023

  • According to the World TB Report 2023, India recorded an average of 199 new infections in every 100,000 people in 2022.
  • An estimated 13% of treated patients and 2.5% of new cases were multi-drug resistant or resistant to the first-line drug rifampicin.
  • Nearly 400,000 people die of TB each year in the country. 

National and international initiatives:

  • National TB Elimination Programme (NTEP)
  • National Strategic Plan (NSP) for Tuberculosis Elimination (2017-2025)
  • TB HaregaDeshJeetega Campaign
  • TB Free India Campaign
  • Revised National Tuberculosis Control Programme (RNTCP)
  • International Union Against
  • Tuberculosis and Lung Disease (The Union)
  • The country aims to accelerate efforts to reduce TB morbidity and mortality, with a target to eliminate TB by 2025.
X

Verifying, please be patient.

Enquire Now